My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Cybin Inc. Common Shares (NY:CYBN)

8.280 UNCHANGED

Last Price Updated: 8:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cybin Inc. Common Shares

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

21 22 Next >

Small Pharma, Cybin Among Top Psychedelic Movers Of Today ↗

September 01, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.57% at $0.27 LOSERS:

Via Benzinga

Psychedelic Stock Gainers And Losers From August 31, 2022 ↗

August 31, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 31.95% at $0.24

Via Benzinga

Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression ↗

August 30, 2022

Cybin Inc.

Via Benzinga

World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them ↗

August 30, 2022

The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business...

Via Benzinga

Compass Pathways, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

August 30, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 2.83% at $1.09 LOSERS:

Via Benzinga

7 Psychedelics Stocks to Buy for a Big Drug Boom ↗

August 30, 2022

These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, GHRS and MNMD can make great investments

Via InvestorPlace

Small Pharma, Biomind Labs Among Top Psychedelic Movers Of Today ↗

August 29, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 27.51% at $0.18

Via Benzinga

Largest Psychedelic Compound-Based Drug Stocks On A Roll - Up 50% Since End Of June ↗

August 26, 2022

The Psychedelic Compounds-Based Drug Stocks Index went up 9.8% this week and is now up 49.5% since the end of June albeit down 32.6% YTD.

Via Talk Markets

Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗

August 26, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 3.61% at $1.00 LOSERS:

Via Benzinga

Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗

August 24, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 17.87% at $1.22

Via Benzinga

Psychedelic Stock Gainers And Losers From August 23, 2022 ↗

August 23, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 5.33% at $14.24

Via Benzinga

Small Pharma, Cybin Among Top Psychedelic Movers Of Today ↗

August 22, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 10.34% at $0.16

Via Benzinga

Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today ↗

August 19, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 29.35% at $0.14 LOSERS:

Via Benzinga

Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session ↗

August 19, 2022

Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday.

Via Benzinga

Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

August 18, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From August 17, 2022 ↗

August 17, 2022

Via Benzinga

BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression ↗

August 17, 2022

Cybin Inc. (NEO: CYBN) (NYSE: CYBN) and Clinilabs Drug Development Corporation (Clinilabs) announced that the U.S.

Via Benzinga

Psychedelic Stock Gainers And Losers From August 16, 2022 ↗

August 16, 2022

Via Benzinga

These Depression Players Are Top Picks For $400B Mental Healthcare Market, Says Analyst ↗

August 16, 2022

HC Wainwright expects COMPASS Pathways Plc (NASDAQ: CMPS) and Cybin Inc (NYSE: CYBN) to be leaders in the emerging $400 billion mental healthcare market.

Via Benzinga

Allied, Cybin Among Top Psychedelic Movers Of Today ↗

August 15, 2022

Via Benzinga

Major Psychedelic Stocks Down This Week; Still Up Since End Of June ↗

August 14, 2022

The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index dropped 8.4% this week for the first time in 5 weeks but are still up 45.3% since then.

Via Talk Markets

Mind Medicine, Numinus Wellness Among Top Psychedelic Movers From Today ↗

August 12, 2022

Via Benzinga

Compass Pathways, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

August 11, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From August 10, 2022 ↗

August 10, 2022

Via Benzinga

3 Best Psychedelic Stocks to Buy Now ↗

August 09, 2022

These are three of the best psychedelic stocks to buy to get in on the next generation of treatment for mental health disorders.

Via InvestorPlace

This Psychedelics Company Is Setting Up An Equity Program For Up To $35M In Shares ↗

August 09, 2022

Cybin Inc. (NEO: CYBN) (NYSE: CYBN) has launched an at-the-market (ATM) equity program through which it will issue and sell up to $35 million in common shares in the company’s capital, from the...

Via Benzinga

Cybin, Field Trip Health Among Top Psychedelic Movers Of Today ↗

August 09, 2022

Via Benzinga

GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today ↗

August 05, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80

Via Benzinga

Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

August 08, 2022

Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6...

Via Benzinga

Psychedelic Stock Gainers And Losers From August 4, 2022 ↗

August 04, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 10.64% at $12.17

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.